Invesaro

Stocks Comparison

Cardiff Lexington vs LifeMD: revenue, profit, margins and growth compared

Cardiff Lexington brought in $11.5M of revenue in fiscal 2025, LifeMD $194.1M in fiscal 2025. Revenue changed by +39.5% at Cardiff Lexington and +25.3% at LifeMD on the year before, so Cardiff Lexington grew faster. Cardiff Lexington kept -47.7% of its revenue as net profit, LifeMD 7.4%.

Side by side, latest fiscal year

CDIXLFMD
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$11.5M$194.1M
Revenue growth+39.5%+25.3%
Net income-$5.5M$14.4M
Net margin-47.7%7.4%
Free cash flown/a$6.4M
Free cash flow marginn/a3.3%
Earnings per share (diluted)n/a$0.25
Cash$318.5K$36.8M
Debt$18.6Mn/a
Price to earningsn/a11.7
Market value$6.6M$141.2M
Dividend yieldn/an/a
Rank by revenue in sector#508 of 742 · Health care#272 of 742 · Health care

Over the years

Revenue
CDIX FY2018: $2.2MCDIX FY2019: $4.5MCDIX FY2020: $3.5MCDIX FY2021: $9.9MCDIX FY2022: $10.7MCDIX FY2023: $11.9MCDIX FY2024: $8.3MCDIX FY2025: $11.5MLFMD FY2018: $8.3MLFMD FY2019: $12.5MLFMD FY2020: $37.3MLFMD FY2021: $92.9MLFMD FY2022: $119MLFMD FY2023: $152.5MLFMD FY2024: $154.8MLFMD FY2025: $194.1MFY18FY19FY20FY21FY22FY23FY24FY25
CDIX $11.5MLFMD $194.1M
Net income
CDIX FY2018: -$6.3MCDIX FY2019: -$7.2MCDIX FY2020: -$2.8MCDIX FY2021: $666.3KCDIX FY2022: -$5.4MCDIX FY2023: $3MCDIX FY2024: -$3.3MCDIX FY2025: -$5.5MLFMD FY2018: -$1.2MLFMD FY2019: -$3.1MLFMD FY2020: -$58.6MLFMD FY2021: -$60.9MLFMD FY2022: -$45.5MLFMD FY2023: -$20.6MLFMD FY2024: -$21.4MLFMD FY2025: $14.4MFY18FY19FY20FY21FY22FY23FY24FY25
CDIX -$5.5MLFMD $14.4M
Net margin
CDIX FY2018: -281.3%CDIX FY2019: -158.1%CDIX FY2020: -82.2%CDIX FY2021: 6.7%CDIX FY2022: -50.8%CDIX FY2023: 25.5%CDIX FY2024: -39.9%CDIX FY2025: -47.7%LFMD FY2018: -14.9%LFMD FY2019: -25.2%LFMD FY2020: -157.3%LFMD FY2021: -65.6%LFMD FY2022: -38.3%LFMD FY2023: -13.5%LFMD FY2024: -13.8%LFMD FY2025: 7.4%FY18FY19FY20FY21FY22FY23FY24FY25
CDIX -47.7%LFMD 7.4%
Revenue growth
CDIX FY2019: +103.9%CDIX FY2020: -24.0%CDIX FY2021: +186.1%CDIX FY2022: +8.2%CDIX FY2023: +10.8%CDIX FY2024: -30.2%CDIX FY2025: +39.5%LFMD FY2019: +49.8%LFMD FY2020: +199.1%LFMD FY2021: +149.0%LFMD FY2022: +28.2%LFMD FY2023: +28.2%LFMD FY2024: +1.5%LFMD FY2025: +25.3%FY19FY20FY21FY22FY23FY24FY25
CDIX +39.5%LFMD +25.3%
Free cash flow
CDIX FY2018: -$2MCDIX FY2020: -$903.4KCDIX FY2021: -$853.5KCDIX FY2022: -$1.2MLFMD FY2021: -$33.3MLFMD FY2022: -$23.3MLFMD FY2023: $8.6MLFMD FY2024: $16MLFMD FY2025: $6.4MFY18FY20FY21FY22FY23FY24FY25
CDIX -$1.2MLFMD $6.4M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cardiff Lexington and LifeMD

Which is bigger by revenue, Cardiff Lexington or LifeMD?

LifeMD is bigger by revenue: $194.1M in fiscal 2025, against $11.5M for Cardiff Lexington in fiscal 2025.

Which keeps more of its revenue as profit, Cardiff Lexington or LifeMD?

Cardiff Lexington had a net margin of -47.7% in fiscal 2025; LifeMD had 7.4% in fiscal 2025.

Which grew revenue faster, Cardiff Lexington or LifeMD?

In their latest fiscal years revenue changed by +39.5% at Cardiff Lexington and +25.3% at LifeMD.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies